Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.

Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Clinical and vaccine Immunology: CVI (Impact Factor: 2.6). 02/2012; 19(4):527-35. DOI: 10.1128/CVI.05653-11
Source: PubMed

ABSTRACT Lyme disease in the United States is caused by Borrelia burgdorferi sensu stricto, which is transmitted to mammals by infected ticks. Borrelia spirochetes differentially express immunogenic outer surface proteins (Osp). Our aim was to evaluate antibody responses to Osp antigens to aid the diagnosis of early infection and the management of Lyme disease. We analyzed antibody responses during the first 3 months after the experimental infection of dogs using a novel multiplex assay. Results were compared to those obtained with two commercial assays detecting C6 antigen. Multiplex analysis identified antibodies to OspC and C6 as early as 3 weeks postinfection (p.i.) and those to OspF by 5 weeks p.i. Antibodies to C6 and OspF increased throughout the study, while antibodies to OspC peaked between 7 and 11 weeks p.i. and declined thereafter. A short-term antibody response to OspA was observed in 3/8 experimentally infected dogs on day 21 p.i. Quant C6 enzyme-linked immunosorbent assay (ELISA) results matched multiplex results during the first 7 weeks p.i.; however, antibody levels subsequently declined by up to 29%. Immune responses then were analyzed in sera from 125 client-owned dogs and revealed high agreement between antibodies to OspF and C6 as robust markers for infection. Results from canine patient sera supported that OspC is an early infection marker and antibodies to OspC decline over time. The onset and decline of antibody responses to B. burgdorferi Osp antigens and C6 reflect their differential expression during infection. They provide valuable tools to determine the stage of infection, treatment outcomes, and vaccination status in dogs.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Reported cases of Lyme disease (a chronic disease caused by infection with Borrelia burgdorferi) in humans increased more than two-fold between 1992 and 2006 in the United States. Recently, the annual number of reported human Lyme disease cases stabilized (according to the Center for Disease Control and Prevention) but the geographic distribution seemed to increase. In New York (NY) State, USA, a spread from the original Lyme disease focus in southeastern parts of the state has occurred. We determined incidence risks of new companion animal infection in 2011 with B. burgdorferi by county in 451 dog and 2100 horse sera; the samples were non-randomly collected by referring veterinarians in NY State between June 15, 2011 and January 31, 2012 because of suspicion of infection with B. burgdorferi or during annual health checks. All samples were submitted to the New York State Animal Health Center; the samples were submitted from 50 out of 62 counties in the state. Incident infections were determined by measuring antibodies to outer surface protein C (OspC; a marker of early infection that is detectable in serum from 3 weeks to 5 months after infection). Incident infections with B. burgdorferi were detected in 23% (95% confidence interval (CI): 19, 27) of canine samples and in 8% (95%CI: 7, 10) of equine samples. In 21 counties, samples were submitted from only one species (i.e. only dogs or only horses) that indicated incident infection. Recognition of incidence infections in dogs and horses might serve as a sentinel for infected ticks in different NY State counties; detection of the OspC antigen can provide a sensitive, new tool to allow recognition of risk for possible human and animal infection with B. burgdorferi by geographic region. We recommend that both dogs and horses be part of such a passive surveillance system.
    Preventive Veterinary Medicine 07/2012; · 2.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: REASONS FOR PERFORMING STUDY: Lyme disease is caused by Borrelia burgdorferi, which is transmitted by infected ticks (Ixodes spp.). Reports on Lyme disease in horses have increased in recent years. Nevertheless, the diagnosis of Lyme disease in horses is still challenging owing to its vague clinical presentation and the limitations of diagnostic tests. OBJECTIVES: This study used a new serological Lyme multiplex assay to examine antibody responses to 3 antigens of B. burgdorferi, outer surface protein (Osp) C, OspF and C6, and to verify their use as markers for early and late infection stages in horses. METHODS: Multiplex analysis of antibodies to OspC, OspF and C6 in equine patient sera (n = 191) was performed. A subset of the sera (n = 90) was also tested using a commercial C6-based Lyme test. RESULTS: Antibodies to OspF and C6 highly correlate as reliable markers of infection with B. burgdorferi in horses. Antibodies to OspC, which have been confirmed as early infection markers in man and dogs, were only detected in some patient sera, suggesting that OspC antibodies are indicators of early infection in horses. Commercial C6 testing identified most infected horses but also resulted in false positive and false negative interpretations. CONCLUSIONS: Serological multiplex testing is a rapid and quantitative diagnostic method to confirm infection with B. burgdorferi and to identify the stage of infection. In horses with risk of exposure and clinical signs, multiplex testing supports the diagnosis of Lyme disease. POTENTIAL RELEVANCE: Antimicrobial treatment of B. burgdorferi is time sensitive. Treatment success decreases with time of persistent infection, while the risk of developing chronic disease increases. The ability to identify early infection with B. burgdorferi provides practitioners and clinicians with a tool to improve the diagnosis of equine Lyme disease and make treatment decisions.
    Equine Veterinary Journal 12/2012; · 2.29 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014